Barriga, Francisco M. http://orcid.org/0000-0002-0996-7707
Lowe, Scott W.
Article History
Received: 1 June 2023
Accepted: 21 November 2023
First Online: 7 February 2024
Competing interests
: S.W.L. is a consultant and holds equity in Blueprint Medicines, ORIC Pharmaceuticals, Mirimus, PMV Pharmaceuticals, Faeth Therapeutics, and Senescea Therapeutics and is a consultant for Fate Therapeutics. F.M.B. declares no competing interests.